Themed Collection: Advances and future directions in pheochromocytoma and paraganglioma


Endocrine-Related Cancer Advances and future directions in pheochromocytoma and paraganglioma collection banner


Endocrine-Related Cancer is pleased to announce a themed collection entitled Advances and future directions in pheochromocytoma and paraganglioma.

Research on pheochromocytoma and paraganglioma has made remarkable progress over the past 20 years. Researchers and clinicians unraveled the genetic complexity of this disease, demonstrated the important contribution of susceptibility genes to tumor pathophysiology, and identified somatic or circulating biomarkers for better patient management. Experimental models have been generated to promote mechanistic research and test innovative therapeutic approaches and numerous clinical trials are underway. In the steps of the 6th International symposium on Pheochromocytoma and Paraganglioma, this collection will highlight the most recent advances and perspectives of the field, with renown experts commenting on the latest research related to genetics, metabolomics, nuclear medicine, preclinical models, and mitochondrial dysfunction. Several other current topics will also be addressed.

If you are interested in contributing an original research article to this collection, please submit your article proposal to


Articles published within the special collection:


Succinate dehydrogenase and MYC-associated factor X mutations in pituitary neuroendocrine tumours
Paul Benjamin Loughrey, Federico Roncaroli, Estelle Healy, Philip Weir, Madhu Basetti, Ruth T Casey, Steven J Hunter and Márta Korbonits


Collection Editors


Dr Roderick Clifton-Bligh
Kolling Institute of Medical Research
The University of Sydney
Sydney, Australia


Dr Judith Favier
Paris Cardiovascular Research Center
Paris, France


Dr Karel Pacak
National Institutes of Health
Maryland, USA